Close Menu

NEW YORK (GenomeWeb) – Inozyme Pharma said today that it is instituting a no-cost genetic testing program in partnership with Wisconsin-based PreventionGenetics to improve the detection and understanding of two rare calcification disorders for which the drugmaker is developing treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.